HPA Axis Study in Japanese Adults

Status:
Completed

Trial end date:
2012-04-01

Target enrollment:

Participant gender:

A multicenter, open-label study to evaluate the adrenal suppression potential of Mapracorat 0.1% ointment in Japanese adults with atopic dermatitis.

Phase 2

Bayer